Precision Medicine in Diabetes, Current Research and Future Perspectives
1Pediatric Diabetology Unit, S.Chiara Hospital of Trento, Largo Medaglie d'Oro, 9, 38122 Trento, Italy.
Journal of Personalized Medicine
|August 26, 2022
Summary
Diabetes prevalence has tripled in 20 years, with 700 million adults projected to be affected by 2050. This highlights a growing global health crisis requiring urgent attention and intervention strategies.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Epidemiology
Background:
- The global prevalence of diabetes mellitus has tripled over the last two decades.
- Projections indicate a continued rise, potentially affecting 700 million adults by 2050.
- This escalating trend underscores the urgent need for effective public health interventions.
Discussion:
- The increasing incidence of diabetes poses a significant challenge to healthcare systems worldwide.
- Understanding the drivers of this epidemic is crucial for developing targeted prevention and management strategies.
- Early detection and lifestyle interventions are key to mitigating the long-term health consequences.
Key Insights:
- Diabetes mellitus is a rapidly growing global health concern.
- The disease burden is expected to increase substantially in the coming decades.
- Addressing the diabetes epidemic requires a multi-faceted approach involving research, policy, and patient education.
Outlook:
- Continued research into diabetes pathogenesis and treatment is essential.
- Public health initiatives focused on prevention and early management are critical.
- International collaboration will be vital to combat the global diabetes crisis.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
342
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
342
Diabetes Mellitus: Overview and Type I Subtype
3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Diabetes Mellitus: Type 2 and Gestational
2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Diabetes: Symptoms, Diagnosis, and Complications
666
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
666


